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RPeriatrial Epicardial Fat, Local
Pro- and Anti-Inflammatory
Balance, and Atrial Fibrillation
We congratulate Al Chekakie et al. (1) for their interesting study
on the relationship between pericardial fat volume and atrial
fibrillation (AF). The authors proposed that the local effects of the
proinflammatory cytokines released from the pericardial adipose
tissue maybe a potential mechanism. However, 2 recent studies
(2,3) indicate that periatrial epicardial fat, not periventricular fat,
was associated with AF. Abed et al. (2) demonstrated that
periatrial fat volume, but not periventricular fat or total fat, was
associated with severity of AF in a multivariate-adjusted model
including age, sex, body mass index, hypertension, obstructive
sleep apnea, and left atrial area. Batal et al. (3) also showed that
periatrial fat thickness between the left atrium and esophagus was
an independent risk factor for AF after adjusting age, body mass
index, and left atrial area. Therefore, further analysis from the data
on periatrial fat volume in the current study may be warranted to
clarify this issue.
Furthermore, pericardial adipose tissue has both proinflamma-
tory and anti-inflammatory characteristics (4). Epicardial fat is a
source of several proinflammatory cytokines, including tumor
necrosis factor-alpha, interleukin-1, and interleukin-6. However, it
also secretes adiponectin with insulin-sensitizing and anti-
inflammatory effects. Very recently, Kourliouros et al. (5) showed
that an increased adiponectin release from epicardial fat was
associated with freedom from AF after cardiac surgery. Regulation
of local proinflammatory and anti-inflammatory balance in peria-
trial adipose tissue may be an important therapeutic target in the
prevention of AF.
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Reply
We thank Drs. Liu and Li for their remarks and interest in our
work (1). The spatial distribution of adipose tissue around the
heart is variable, with patches of fat adjacent to myocardium.
Furthermore, significant heterogeneity of fat distribution exists
among individuals, which makes it difficult to use a single regional
measurement as a representative surrogate of actual overall volume
or distribution. Total pericardial fat volume has been shown to be
a risk factor for atrial fibrillation (AF) in our study as well as in
others (1,2). A recent article on the Framingham study showed
that pericardial fat was associated with prevalent AF even after
correction for other risk factors (2). That study, as well as ours, did
not compartmentalize the fat areas, and instead reported the entire
pericardial fat volume, which is the most widely accepted method
of measurement. We agree with Drs. Liu and Li that the
distinction between atrial and ventricular pericardial fat is of
interest and that the optimal method of measurement of adipose
tissue in these specific compartments needs to be defined. Impor-
tantly, the mechanisms by which pericardial fat predisposes to AF
need to be elucidated. It is reasonable to hypothesize an inflam-
matory mechanism based on the paracrine properties of visceral
adipose tissue (3). As such, the exact regional distribution of fat
may not be relevant, because there are no barriers in the pericar-
dium separating the atria from the ventricles and thereby preclud-
ing local effects. We agree with Drs. Liu and Li that this
relationship may represent an important therapeutic target for AF,
and we look forward to future studies that shed light on the
pathophysiological mechanisms.
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